BioInnovation Institute (BII)

About BioInnovation Institute (BII)

Nonprofit institute backed by Novo Nordisk Foundation with ~€736M (2026-2035) to scale life science innovation across Europe. Will expand beyond biotech into AI and quantum tech.

Investment Focus

Location / RegionDenmark

Funding StagePre Seed

Industry Focus

Ai Ml

Biotech

Deep Tech

Investor Signals Profile

active

Sweet Spot

Academic scientist-founder in health or deep tech

life sciences

deep tech

quantum tech

biotech/health

academic spinouts

Bullish Signals

€145M total funding deployedexternal

1.1B external raised by alumniexternal

142 startups built to dateexternal

21 products on marketexternal

NATO DIANA quantum collaborationexternal

Up to DKK 4M Venture Lab fundingexternal

Up to DKK 5.35M/yr Brain Health Bio Studioexternal

Plug-and-play lab & office spaceexternal

3 structured programs: 6M/1Y/3Yexternal

Societal resilience added as thesis pillarexternal

Contrarian Signals

Program-based, not pure VC fundexternal

Danish/Nordic geographic focus likelyexternal

Academic origin may slow commercializationexternal

Founder Do's

Science-based, translatable research

Focus on human or planetary health

Apply via open call programs

Seek lab/office space at BII

Target early-stage venture validation

Founder Don'ts

Non-science-based business models

Skip open call application process

Avoid if no R&D component

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€736M

Saves0

Website

Key People

Novo Nordisk Foundation